Answers are grounded in this paper and cite their sources.
Quasi experimental study shows significant weight reduction in non-diabetic obese patients, indicating semaglutide's efficacy.
Objective: To determine the efficacy of Semaglutide in weight reduction in non-diabetic obese patients. Study Design: Quasi experimental study Place and Duration of Study: This study was conducted at the OPDs of Liaquat University Hospital Hyderabad/Jamshoro & Saddar Hyderabad from 1st July 2024 to 31st March 2025. Methods: Two hundred and sixty nine patients from either gender, age range between 27 and 45 and body mass index >24.5 were enrolled. Fifty patients were drooped at 2nd week and 6th week due to financial reasons. The sampling technique was non-probability. The Semaglutide started at 0.25 mg weekly for 1st month, 0.5 mg sub cutaneous on 2nd month and 1mg on 3rd month. The reduction of weight >3 % from the baseline at 4thweek and >5% at 3rd month was considered as good efficacy. The body mass index reduced 0.5% from base line to end of third month was considered significant effect of Semaglutide. Results: There were 105 (48%) males and 114 (52%) females with urban 118 (54%) and rural 101 (46%). The age range was 25-49 years with median ~35 years. The pre-semaglutide body mass index of mean 33 and range was 25-42%. After 3 months of treatment, mean body mass index was 32.5 and significant (p<0.0001) indicates a statistically significant reduction in body mass index after Semaglutide treatment. Average weight loss was 4.3 kgover 3 months. Side effects were most common in the youngest group (65%), driven by nausea/vomiting (30%). Visual problems increased with age (10% to 20%), while gastrointestinal symptoms declined. Conclusion: Semaglutide demonstrates potent weight-reduction efficacy in non-diabetic populations, particularly among younger individuals. However, age, gender, and regional factors significantly influence tolerability, necessitating personalized approaches to optimize outcomes.
No takes yet. Share an insight, caveat, or question.
Shaikh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: